| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10966111 | Vaccine | 2015 | 4 Pages |
Abstract
The long-term efficacy of the CHO derived hepatitis vaccine is good and stable for 14-16 years after vaccination. A booster dose seems not necessary. Implementing mother-newborn blocking measures for newborns from HBsAg carrier mothers is urgently needed in the future.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Feng Wang, Jingchen Ma, Zhiyong Hao, Zhiyong Zhang, Xinjiang Zhang, Zhao Gao, Shengli Bi, Liping Shen, Feng Qiu, Yuliang Zhao,